Evaxion Biotech (NASDAQ: EVAX) reported Q3 EPS of $0.01, $0.01 better than the analyst estimate of $0.00. Revenue for the quarter came in at $7.49 million.

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.